Smith Jason Drew bought URGN
January 31, 2026 · Form 4 insider transaction
Smith Jason Drew bought 3,333 shares of UroGen Pharma Ltd., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 11 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,333
Price
N/A
Total value
N/A
InsiderSmith Jason Drew
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateJanuary 31, 2026
Filing dateFebruary 11, 2026
Shares owned after58,805
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.